Welcome to the OMA Blog

Metabolic associated liver disease (MASLD) is the most common chronic liver disease globally, linked to obesity and insulin resistance, with a growing prevalence in children. Early life factors such as maternal BMI, gestational diabetes, and breastfeeding play crucial roles in influencing the risk and progression of MASLD, highlighting the need for further research and preventive measures.

Highlighting Advocacy: Providing care to patients with obesity can be complex. The Obesity and Advocacy joint statement from the Obesity Medicine Association and the Obesity Action Coalition 2024 provides a clinical focus, an action-based framework, and a guide for health care providers.

Understand the link between inflammation, obesity, and how the Dietary Inflammatory Index can help mitigate health risks associated with chronic inflammation.

The Obesity Medicine Association (OMA) is the oldest and largest organization of clinicians in the obesity treatment space. In 2024, it partnered with Project ECHO to create the program entitled, Treating the Disease of Obesity. Ethos of this program includes (1) obesity is a chronic and relapsing disease and (2) the use of person-first language (eg. “the patient with obesity” instead of “the obese patient”). The first session was in February 2024 by Dr. Angela Fitch, the Past President of OMA. She presented the four core pillars of clinical obesity treatment. Content from this presentation is described in this blog article.

Article Summary This article examines the incidence of slipped capital femoral epiphysis (SCFE) trends due to rising obesity rates. Healthcare providers need to monitor those pediatric patients that has the disease of obesity which is a compelling risk factor for developing SCFE along with hypothyroidism, osteodystrophy, or genetic predisposition. During this decade long study the incidence of SCFE surged from 2.46 to 5.96 per 10,000 children which according to the authors had a mirroring increase with childhood obesity trends. The authors analysis showed a similar concurrent rise of SCFE and obesity trends, however, they emphasized not trying to imply causality. Obesity is a major risk factor for developing SCFE in the pediatric population, which often presents with hip abnormalities.. The marked increase in SCFE during the same decade as the rise in obesity may indicate correlation between the two trends. The observation however did highlight one of the risk factors being obesity which could increase one’s risk of developing SCFE.

Discover how weight loss medications affect pregnancy and fertility with the latest insights, research, and safety recommendations for patients.

Growing up as the youngest of three children to high school teachers, Dr. Caissa Troutman was immersed in the importance of education from an early age. With a curiosity and a love for learning, Dr. Troutman was naturally drawn to medicine. "I think that was why I gravitated towards medicine," she reflects. "It was learning to understand how things worked—the puzzle of the human body."

In an effort to combat obesity, the Mississippi Obesity Society stands as a strong example of the dedication and compassion that is needed to address a disease like obesity. Founded just a year ago, this dynamic organization is dedicated to improving the lives of Mississippians by enhancing health awareness and access to resources.

We love visiting Denver due to its unique cultural discoveries and unique outdoor spaces. While Denver is famous for having one of the most walkable downtowns in the US, we also visit the city for our favorite spots like Little Man Ice Cream, Queen City Coffee, and Rosenberg's Bagels. This year, we had another reason to be excited about Denver: it hosted the Obesity Medicine Conference 2024!